The Mechanisms of Action of Hyperbaric Oxygen in Restoring Host Homeostasis during Sepsis
Open Access
- 7 August 2023
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 13 (8) , 1228
Abstract
The perception of sepsis has shifted over time; however, it remains a leading cause of death worldwide. Sepsis is now recognized as an imbalance in host cellular functions triggered by the invading pathogens, both related to immune cells, endothelial function, glucose and oxygen metabolism, tissue repair and restoration. Many of these key mechanisms in sepsis are also targets of hyperbaric oxygen (HBO2) treatment. HBO2 treatment has been shown to improve survival in clinical studies on patients with necrotizing soft tissue infections as well as experimental sepsis models. High tissue oxygen tension during HBO2 treatment may affect oxidative phosphorylation in mitochondria. Oxygen is converted to energy, and, as a natural byproduct, reactive oxygen species are produced. Reactive oxygen species can act as mediators, and both these and the HBO2-mediated increase in oxygen supply have the potential to influence the cellular processes involved in sepsis. The pathophysiology of sepsis can be explained comprehensively through resistance and tolerance to infection. We argue that HBO2 treatment may protect the host from collateral tissue damage during resistance by reducing neutrophil extracellular traps, inhibiting neutrophil adhesion to vascular endothelium, reducing proinflammatory cytokines, and halting the Warburg effect, while also assisting the host in tolerance to infection by reducing iron-mediated injury and upregulating anti-inflammatory measures. Finally, we show how inflammation and oxygen-sensing pathways are connected on the cellular level in a self-reinforcing and detrimental manner in inflammatory conditions, and with support from a substantial body of studies from the literature, we conclude by demonstrating that HBO2 treatment can intervene to maintain homeostasis.Keywords
Funding Information
- Innovationsfonden (8113-00009B, 8114-00005B, 8114-00005B)
- Innovationsfonden (8113-00009B, 8114-00005B, 8114-00005B)
This publication has 172 references indexed in Scilit:
- The Ketogenic Diet and Hyperbaric Oxygen Therapy Prolong Survival in Mice with Systemic Metastatic CancerPLOS ONE, 2013
- Hyperbaric oxygen therapy improves early posttransplant islet functionPediatric Diabetes, 2010
- Heme oxygenase-1 affords protection against noncerebral forms of severe malariaProceedings of the National Academy of Sciences, 2009
- Oxidative stress is fundamental to hyperbaric oxygen therapyJournal of Applied Physiology, 2009
- Hyperbaric oxygen stimulates vasculogenic stem cell growth and differentiation in vivoJournal of Applied Physiology, 2009
- Regulation of hypoxia-inducible factor-1α by NF-κBBiochemical Journal, 2008
- Up-regulated HIF-1α is involved in the hypoxic tolerance induced by hyperbaric oxygen preconditioningBrain Research, 2008
- NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1αNature, 2008
- Reactive oxygen species and cellular oxygen sensingFree Radical Biology and Medicine, 2007
- Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significanceOncogene, 2006